Image Weight Loss Centers

Image Weight Loss Centers operates in Houston, TX, under the medical direction of Dr. Ahl Sahli, focusing exclusively on physician-supervised weight loss programs that incorporate prescription peptide therapies alongside comprehensive metabolic assessment. The clinic structures its approach around individualized treatment plans that account for each patient's metabolic profile, weight loss history, and health conditions rather than applying standardized protocols. With in-person consultations required for all new patients, the Houston location emphasizes direct physician oversight throughout the weight loss process, from initial evaluation through ongoing medication management and progress monitoring.

The clinic's peptide therapy offerings center on three GLP-1 receptor agonists and dual-action medications: semaglutide, tirzepatide, and retatrutide. Semaglutide works by mimicking the GLP-1 hormone to regulate appetite and slow gastric emptying, administered as a weekly subcutaneous injection with dosing titrated based on individual response and tolerance. Tirzepatide functions as both a GLP-1 and GIP receptor agonist, targeting two incretin pathways simultaneously to influence blood sugar regulation and satiety signaling. Retatrutide represents a triple-agonist approach, activating GLP-1, GIP, and glucagon receptors, and is positioned for patients who may benefit from this expanded mechanism of action. Image Weight Loss Centers determines peptide selection through metabolic testing, body composition analysis, and assessment of factors including insulin resistance markers and previous weight loss medication history. Patients receive injection training, dosage schedules, and protocols for managing potential side effects such as nausea or gastrointestinal adjustment during the titration phase.

Dr. Ahl Sahli directs the medical protocols at Image Weight Loss Centers, overseeing patient evaluations, prescribing decisions, and treatment modifications based on clinical response. The clinic requires baseline laboratory work before initiating peptide therapy, typically including comprehensive metabolic panels, thyroid function tests, and hemoglobin A1c to identify contraindications and establish metabolic baselines. Follow-up visits occur at regular intervals determined by the specific peptide protocol and individual patient needs, with weight, body composition, and side effect assessment documented at each appointment. Dr. Sahli's approach incorporates medication management as one component within a broader framework that addresses dietary patterns, activity levels, and behavioral factors influencing long-term weight maintenance. The Houston clinic does not offer telehealth consultations, requiring all patient interactions to occur at the physical location for hands-on assessment and injection technique verification.

Patients beginning treatment at Image Weight Loss Centers in Houston undergo an initial consultation that includes medical history review, physical examination, discussion of weight loss goals, and explanation of available peptide options with their respective mechanisms and expected timelines. The clinic provides specific guidance on injection administration, storage requirements for peptides, and recognition of adverse effects that warrant clinical contact. Treatment plans typically span several months, with dosage adjustments made based on weight loss velocity, tolerance, and metabolic markers tracked through periodic lab work. The center supplies patients with injection supplies, sharps disposal containers, and written protocols for their prescribed regimen. Nutritional guidance accompanies peptide therapy, though the clinic's primary focus remains medical management rather than intensive dietary counseling or meal planning services.

Image Weight Loss Centers differentiates itself through its concentration on peptide-based medical weight loss rather than surgical interventions or non-prescription approaches, serving Houston-area patients who seek physician-directed pharmacological treatment. The clinic's in-person requirement reflects its emphasis on direct medical supervision and hands-on patient education, particularly regarding injection technique and side effect management. With a 4.1-star rating across 33 Google reviews, patient feedback indicates variability in experiences, suggesting prospective patients should clarify expectations regarding appointment availability, communication protocols, and the level of ongoing support provided between scheduled visits. The Houston location serves patients specifically seeking access to newer peptide therapies including retatrutide, which remains less widely available than established options like semaglutide, under direct physician oversight in a dedicated weight loss practice setting.